ACCOLADE INC (ACCD)
US00437E1029 - Common Stock
Overall ACCD gets a fundamental rating of 3 out of 10. We evaluated ACCD against 117 industry peers in the Health Care Providers & Services industry. The financial health of ACCD is average, but there are quite some concerns on its profitability. ACCD is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ACCD has reported negative net income.
In the past year ACCD has reported a negative cash flow from operations.
In the past 5 years ACCD always reported negative net income.
In the past 5 years ACCD always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -15.63%, ACCD is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -28.23%, ACCD is in line with its industry, outperforming 40.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.63% | ||
| ROE | -28.23% | ||
| ROIC | N/A |
ROA(3y)-23.71%
ROA(5y)-45.45%
ROE(3y)-41.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 44.81%, ACCD is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of ACCD has grown nicely.
ACCD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.81% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y8.22%
2. Health
2.1 Basic Checks
ACCD does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACCD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -0.49, we must say that ACCD is in the distress zone and has some risk of bankruptcy.
ACCD has a worse Altman-Z score (-0.49) than 68.10% of its industry peers.
ACCD has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
ACCD's Debt to Equity ratio of 0.48 is fine compared to the rest of the industry. ACCD outperforms 62.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.49 |
ROIC/WACCN/A
WACC6.53%
2.3 Liquidity
A Current Ratio of 2.35 indicates that ACCD has no problem at all paying its short term obligations.
The Current ratio of ACCD (2.35) is better than 81.90% of its industry peers.
ACCD has a Quick Ratio of 2.35. This indicates that ACCD is financially healthy and has no problem in meeting its short term obligations.
ACCD has a Quick ratio of 2.35. This is amongst the best in the industry. ACCD outperforms 83.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 |
3. Growth
3.1 Past
ACCD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.79%, which is quite impressive.
ACCD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.55%.
Measured over the past years, ACCD shows a very strong growth in Revenue. The Revenue has been growing by 36.44% on average per year.
EPS 1Y (TTM)29.79%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q50%
Revenue 1Y (TTM)8.55%
Revenue growth 3Y39.94%
Revenue growth 5Y36.44%
Revenue growth Q2Q9.26%
3.2 Future
Based on estimates for the next years, ACCD will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.92% on average per year.
ACCD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.93% yearly.
EPS Next Y45.52%
EPS Next 2Y22.1%
EPS Next 3Y15.92%
EPS Next 5YN/A
Revenue Next Year14.73%
Revenue Next 2Y16.47%
Revenue Next 3Y17%
Revenue Next 5Y18.93%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
ACCD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ACCD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ACCD's earnings are expected to grow with 15.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.1%
EPS Next 3Y15.92%
5. Dividend
5.1 Amount
ACCD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ACCOLADE INC
NASDAQ:ACCD (4/26/2024, 7:00:00 PM)
After market: 7.97 +0.08 (+1.01%)7.89
-1.3 (-14.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap610.76M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.63% | ||
| ROE | -28.23% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.81% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)29.79%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y45.52%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.55%
Revenue growth 3Y39.94%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y